首页> 美国卫生研究院文献>Journal of Veterinary Science >Clinical assessment of the efficacy of supraglottic airway devices compared with endotracheal tubes in cats during volume-controlled ventilation
【2h】

Clinical assessment of the efficacy of supraglottic airway devices compared with endotracheal tubes in cats during volume-controlled ventilation

机译:容积控制通气期间声门上气道器械与气管插管相比在猫中的疗效的临床评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The efficacies of a supraglottic airway device (SGAD) and an endotracheal tube (ETT) in cats under general anesthesia with volume-controlled ventilation (VCV) were compared. Thirty healthy cats were randomly allocated for airway control using either an SGAD or an ETT. Five tidal volumes (6, 8, 10, 12, and 14 mL/kg) were randomly tested, and respiratory rates were adjusted to achieve a minute ventilation of 100 mL/kg/min. The dose of propofol necessary to insert the SGAD or ETT, the static respiratory pressure, leakage during VCV, and end tidal CO (ETCO ) were recorded. Dosages of propofol and static respiratory measurements for the SGAD and ETT groups were compared using a -test. The distribution of leakages and hypercapnia (ETCO > 45 mmHg) were compared using Fisher's exact test. A significance level of < 0.05 was established. No significant difference in dose of propofol was observed between the SGAD and ETT groups (7.1 ± 1.0, 7.3 ± 1.7 mg/kg; = 0.55). Static resistance pressure of the SGAD (22.0 ± 8.1 cmH O/L/sec) was significantly lower than that of the ETT (36.6 ± 12.9 cmH O/L/sec; < 0.01). Of the 75 trials, leakage was more frequent when using an SGAD (8 events) than when using an ETT (1 event; = 0.03). Hypercapnia occurred more frequently with SGAD (18 events) than with ETT (3 events; < 0.01). Although intubation with an ETT is the gold standard in small animal anesthesia, the use of an SGAD can reduce airway resistance and the work of breathing. Nonetheless, SGAD had more dead space and the tidal volume for VCV needs adjustment.
机译:比较了在全身麻醉和容积控制通气(VCV)下猫的声门上气道装置(SGAD)和气管导管(ETT)的疗效。使用SGAD或ETT将30只健康的猫随机分配用于气道控制。随机测试了五个潮气量(6、8、10、12和14 mL / kg),并调整了呼吸频率,以实现100 mL / kg / min的分钟通气量。记录插入SGAD或ETT所需的异丙酚剂量,静态呼吸压力,VCV期间的渗漏以及潮气末CO(ETCO)。使用-test比较SGAD和ETT组的异丙酚剂量和静态呼吸测量结果。使用Fisher精确检验比较渗漏和高碳酸血症的分布(ETCO> 45 mmHg)。建立显着性水平<0.05。 SGAD组和ETT组之间没有观察到丙泊酚剂量的显着差异(7.1±1.0,7.3±1.7 mg / kg; = 0.55)。 SGAD的静电阻压力(22.0±8.1 cmH O / L / sec)明显低于ETT(36.6±12.9 cmH O / L / sec; <0.01)。在75个试验中,使用SGAD(8个事件)比使用ETT(1个事件; = 0.03)时的泄漏更为频繁。 SGAD(18事件)的高碳酸血症发生频率比ETT(3事件; <0.01)高。尽管使用ETT插管是小动物麻醉的金标准,但使用SGAD可以降低呼吸道阻力和呼吸功。但是,SGAD的死区更多,需要调整VCV的潮气量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号